HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion

被引:129
作者
Agnello, D
Wang, HC
Yang, H
Tracey, KJ
Ghezzi, P
机构
[1] Mario Negri Inst Pharmacol Res, Lab Neuroimmunol, I-20157 Milan, Italy
[2] N Shore Univ Hosp, Lab Biomed Sci, Manhasset, NY USA
关键词
D O I
10.1006/cyto.2002.0890
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-mobility group protein-1 (HMG-1 also termed HMGB-1), a DNA-binding protein, regulates gene transcription and stabilizes nucleosome formation. HMG-1 was recently implicated as a cytokine, because it is a late-acting mediator of endotoxin lethality that induces the release of pro-inflammatory cytokines from monocytes. Here it is shown that administration of HMG-1 into the cerebral ventricles decreases food intake (food intake=4.6 g/mouse in controls vs 1.6 g/mouse after 1 mug HMG-1 i.c.v.; P<0.05). Intracerebroventricular HNIG-1 induced an increased in TNF and IL-6 expression in the brain, and mediated taste aversion with potencies equivalent to LIPS. In a model of endotoxemia, passive immunization with anti-HMG-1 antibodies attenuated the development of hypophagia, indicating that HMG-1 is a mediator of sickness behaviour associated with endotoxemia. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 15 条
  • [1] AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
  • [2] High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
    Andersson, U
    Wang, HC
    Palmblad, K
    Aveberger, AC
    Bloom, O
    Erlandsson-Harris, H
    Janson, A
    Kokkola, R
    Zhang, MH
    Yang, H
    Tracey, KJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) : 565 - 570
  • [3] LIMITED IMPORTANCE OF A LEARNED AVERSION IN THE HYPOPHAGIC EFFECT OF INTERLEUKIN-1-BETA
    BAUER, C
    WEINGARTEN, S
    SENN, M
    LANGHANS, W
    [J]. PHYSIOLOGY & BEHAVIOR, 1995, 57 (06) : 1145 - 1153
  • [4] Molecular basis of sickness behavior
    Dantzer, R
    Bluthé, RM
    Gheusi, G
    Cremona, S
    Layé, S
    Parnet, P
    Kelley, KW
    [J]. MOLECULAR MECHANISMS OF FEVER, 1998, 856 : 132 - 138
  • [5] Cytokines and sickness behavior
    Dantzer, R
    Bluthé, RM
    Layé, S
    Bret-Dibat, JL
    Parnet, P
    Kelley, KW
    [J]. NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 : 586 - 590
  • [6] PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
    HALEY, TJ
    MCCORMICK, WG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01): : 12 - 15
  • [7] SICKNESS BEHAVIOR AS A NEW TARGET FOR DRUG DEVELOPMENT
    KENT, S
    BLUTHE, RM
    KELLEY, KW
    DANTZER, R
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (01) : 24 - 28
  • [8] CENTRAL ADMINISTRATION OF THE PEPTIDE ALPHA-MSH INHIBITS INFLAMMATION IN THE SKIN
    LIPTON, JM
    MACALUSO, A
    HILTZ, ME
    CATANIA, A
    [J]. PEPTIDES, 1991, 12 (04) : 795 - 798
  • [9] MERENMIES J, 1991, J BIOL CHEM, V266, P16722
  • [10] RAUVALA H, 1987, J BIOL CHEM, V262, P16625